Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
21.70
+0.45 (2.12%)
Jan 17, 2025, 4:00 PM EST - Market closed
Cidara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 17, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 237 | 72 | 54 | 85 | 88 | 127 | |
| Market Cap Growth | -11.02% | 32.57% | -36.04% | -3.62% | -30.74% | 94.55% | |
| Enterprise Value | 114 | 27 | 3 | 54 | 52 | 65 | |
| Last Close Price | 21.70 | 15.88 | 15.13 | 25.40 | 40.00 | 76.80 | |
| PS Ratio | 2.45 | 3.08 | 2.31 | 1.71 | 7.28 | 6.07 | |
| PB Ratio | 1.32 | -8.75 | -3.75 | 3.93 | 8.20 | 3.35 | |
| P/TBV Ratio | 0.65 | - | - | 3.93 | 8.20 | 3.35 | |
| EV/Sales Ratio | 2.55 | 1.18 | 0.12 | 1.10 | 4.28 | 3.11 | |
| Debt / Equity Ratio | 0.03 | -0.59 | -0.08 | 0.23 | 0.74 | 0.31 | |
| Asset Turnover | 0.40 | 0.41 | 0.38 | 0.73 | 0.19 | 0.28 | |
| Quick Ratio | 2.91 | 0.74 | 0.93 | 1.91 | 1.22 | 1.66 | |
| Current Ratio | 3.54 | 0.90 | 1.09 | 2.11 | 1.48 | 2.18 | |
| Return on Equity (ROE) | -200.46% | - | -608.89% | -263.05% | -297.06% | -84.75% | |
| Return on Assets (ROA) | -23.89% | -29.54% | -22.29% | -38.91% | -69.41% | -35.22% | |
| Return on Capital (ROIC) | -40.88% | - | -204.17% | -116.57% | -131.62% | -43.97% | |
| Earnings Yield | -50.86% | -31.94% | -62.00% | -50.14% | -82.06% | -32.39% | |
| FCF Yield | -67.47% | -31.94% | -52.79% | -29.84% | -62.13% | -22.52% | |
| Buyback Yield / Dilution | -21.86% | -25.15% | -33.18% | -26.22% | -38.83% | -15.71% | |
| Total Shareholder Return | -21.86% | -25.15% | -33.18% | -26.22% | -38.83% | -15.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.